Evidence map›Paper›PMID 33590857›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2021

Exposure to Nicotine and Toxicants Among Dual Users of Tobacco Cigarettes and E-Cigarettes: Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.

Danielle M Smith, Carol Christensen, Dana van Bemmel, Nicolette Borek, Bridget Ambrose, Gladys Erives, Raymond Niaura, Kathryn C Edwards, Cassandra A Stanton, Benjamin C Blount and 10 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Evaluation of Dual Use: Real Time Reductions in Combustible Cigarette Smoking During Co-Occurring Use of E-Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Nicotine and Toxicant Exposure among Individuals using both Combustible Cigarettes and E-cigarettes Based on Level of Product Use.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Danielle M SmithDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-1637-0992
Carol ChristensenOffice of Science, Center for Tobacco Products, Food and Drug Administration (FDA), Silver Spring, MD, USA.
Dana van BemmelOffice of Science, Center for Tobacco Products, Food and Drug Administration (FDA), Silver Spring, MD, USA.
Nicolette BorekOffice of Science, Center for Tobacco Products, Food and Drug Administration (FDA), Silver Spring, MD, USA.
Bridget AmbroseOffice of Science, Center for Tobacco Products, Food and Drug Administration (FDA), Silver Spring, MD, USA.
Gladys ErivesOffice of Science, Center for Tobacco Products, Food and Drug Administration (FDA), Silver Spring, MD, USA.
Raymond NiauraDepartment of Social and Behavioral Sciences, College of Global Public Health, New York University, New York, NY, USA.
Kathryn C EdwardsBehavioral Health & Health Policy Practice, Westat, Rockville, MD, USA.
Cassandra A StantonBehavioral Health & Health Policy Practice, Westat, Rockville, MD, USA.ORCID 0000-0001-5329-6261
Benjamin C BlountTobacco and Volatiles Branch, Division of Laboratory Sciences, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Lanqing WangTobacco and Volatiles Branch, Division of Laboratory Sciences, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Jun FengTobacco and Volatiles Branch, Division of Laboratory Sciences, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Jeffery M JarrettInorganic and Radiation Analytical Toxicology Branch, Division of Laboratory Sciences, Centers for Disease Control (CDC), Atlanta, GA, USA.
Cynthia D WardInorganic and Radiation Analytical Toxicology Branch, Division of Laboratory Sciences, Centers for Disease Control (CDC), Atlanta, GA, USA.
Dorothy HatsukamiUniversity of Minnesota, Masonic Cancer Center, Minneapolis, MN, USA.
Stephen S HechtUniversity of Minnesota, Masonic Cancer Center, Minneapolis, MN, USA.ORCID 0000-0001-7228-1356
Heather L KimmelEpidemiology Research Branch, National Institute of Drug Abuse (NIDA), Bethesda, MD, USA.ORCID 0000-0001-8278-0095
Mark TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Andrew HylandDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Maciej L GoniewiczDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0001-6748-3068
Centers for Disease Control and Prevention · USOffice of Science · USRoswell Park Comprehensive Cancer Center · USUniversity of Minnesota · USWestat (United States) · USNational Institute on Drug Abuse · USNew York University · US

Funding

Intramural CDC HHS CC999999NIDA NIH HHS HHSN271201100027CNIDA NIH HHS HHSN271201600001C
6 · The paper itself

Abstract

introductionConcurrent use of tobacco cigarettes and e-cigarettes ("dual use") is common among tobacco users. Little is known about differences in demographics and toxicant exposure among subsets of dual users. AIMS AND

methodsWe analyzed data from adult dual users (current every/some day users of tobacco cigarettes and e-cigarettes, n = 792) included in the PATH Study Wave 1 (2013-2014) and provided urine samples. Samples were analyzed for biomarkers of exposure to nicotine and selected toxicants (tobacco-specific nitrosamine NNK [NNAL], lead, cadmium, naphthalene [2-naphthol], pyrene [1-hydroxypyrene], acrylonitrile [CYMA], acrolein [CEMA], and acrylamide [AAMA]). Subsets of dual users were compared on demographic, behavioral, and biomarker measures to exclusive cigarette smokers (n = 2411) and exclusive e-cigarette users (n = 247).

resultsMost dual users were predominant cigarette smokers (70%), followed by daily dual users (13%), non-daily concurrent dual users (10%), and predominant vapers (7%). Dual users who smoked daily showed significantly higher biomarker concentrations compared with those who did not smoke daily. Patterns of e-cigarette use had little effect on toxicant exposure. Dual users with high toxicant exposure were generally older, female, and smoked more cigarettes per day. Dual users who had low levels of biomarkers of exposure were generally younger, male, and smoked non-daily.

conclusionsIn 2013-2014, most dual users smoked cigarettes daily and used e-cigarettes occasionally. Cigarette smoking appears to be the primary driver of toxicant exposure among dual users, with little-to-no effect of e-cigarette use on biomarker levels. Results reinforce the need for dual users to stop smoking tobacco cigarettes to reduce toxicant exposure. IMPLICATIONS: With considerable dual use of tobacco cigarettes and e-cigarettes in the United States, it is important to understand differences in toxicant exposure among subsets of dual users, and how these differences align with user demographics. Findings suggest most dual users smoke daily and use e-cigarettes intermittently. Low exposure to toxicants was most common among younger users, males, and intermittent smokers; high exposure to toxicants was most common among older users, females, and heavier cigarette smokers. Results underscore the heterogeneity occurring within dual users, and the need to quit smoking cigarettes completely in order to reduce toxicant exposure.

Indexed as

Electronic Nicotine Delivery SystemsHealth BehaviorAdultBiomarkersCigarette SmokingFemaleHumansMaleMetals, HeavyMiddle AgedNicotineNitrosaminesPolycyclic Aromatic HydrocarbonsPyrenesSmokersTobacco ProductsBiomarkersMetals, HeavyNicotineNitrosaminesPolycyclic Aromatic HydrocarbonspyrenePyrenes

Identifiers

PMID33590857
PMCPMC8095240
OpenAlexW3129380035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.